Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been assigned an average recommendation of “Buy” ...

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) traded down 6.7% during mid-day trading on Tuesday ...

We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a ...

H.C. Wainwright raised the firm’s price target on Soleno Therapeutics (SLNO) to $100 from $70 and keeps a Buy rating on the shares after the ...

Soleno Therapeutics (SLNO) stock skyrocketed up over 42% this past week on news that it has achieved a significant milestone with FDA approval ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO), a biopharmaceutical company focused on developing and commercializing novel therapeutics for rare diseases, has recently achieved a significant milestone ...

Shares of the Redwood City-based Soleno Therapeutics climbed 38% — the biggest one-day gain since September 2023 — to their ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO), a biopharmaceutical company focused on developing and commercializing novel therapeutics for rare diseases, has recently achieved a significant milestone with ...

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading ...

We recently published a list of 10 Stocks Outperform Broader Market Last Week. In this article, we are going to take a look ...